FR2833840B1 - Methodes et compositions pour le traitement de pathologies respiratoires - Google Patents

Methodes et compositions pour le traitement de pathologies respiratoires

Info

Publication number
FR2833840B1
FR2833840B1 FR0208606A FR0208606A FR2833840B1 FR 2833840 B1 FR2833840 B1 FR 2833840B1 FR 0208606 A FR0208606 A FR 0208606A FR 0208606 A FR0208606 A FR 0208606A FR 2833840 B1 FR2833840 B1 FR 2833840B1
Authority
FR
France
Prior art keywords
compositions
methods
treatment
pathologies
respiratory pathologies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0208606A
Other languages
English (en)
Other versions
FR2833840A1 (fr
Inventor
Lionel Bueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rytek Sarl
Original Assignee
Rytek Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0116706A external-priority patent/FR2833839A1/fr
Application filed by Rytek Sarl filed Critical Rytek Sarl
Priority to FR0208606A priority Critical patent/FR2833840B1/fr
Priority to SV2002001439A priority patent/SV2003001439A/es
Priority to UY27589A priority patent/UY27589A1/es
Priority to ARP020104998A priority patent/AR038042A1/es
Priority to AU2002364679A priority patent/AU2002364679A1/en
Priority to TW091136815A priority patent/TW200305447A/zh
Priority to PCT/FR2002/004506 priority patent/WO2003053422A2/fr
Priority to EP02805413A priority patent/EP1455767A2/fr
Priority to US10/324,958 priority patent/US20030125321A1/en
Priority to US10/498,094 priority patent/US20050019314A1/en
Priority to PA20028562701A priority patent/PA8562701A1/es
Priority to CA002470442A priority patent/CA2470442A1/fr
Priority to PE2003000015A priority patent/PE20030853A1/es
Publication of FR2833840A1 publication Critical patent/FR2833840A1/fr
Publication of FR2833840B1 publication Critical patent/FR2833840B1/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

La présente demande concerne des compositions et méthodes pour le traitement de pathologies respiratoires. Elle concerne également des compositions et méthodes permettant de réguler la perméabilité paracellulaire de l'épithélium pulmonaire. Les compositions et méthodes de l'invention reposent notamment sur l'utilisation d'agents ou de conditions modulant la tension du cytosquelette des cellules épithéliales pulmonaires, notamment des entérocytes. L'invention est utilisable pour le traitement préventif ou curatif de pathologies variées, telles que asthme, allergies, maladies obstructives, etc., chez les mammifères, notamment les humains.
FR0208606A 2001-12-21 2002-07-09 Methodes et compositions pour le traitement de pathologies respiratoires Expired - Fee Related FR2833840B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0208606A FR2833840B1 (fr) 2001-12-21 2002-07-09 Methodes et compositions pour le traitement de pathologies respiratoires
SV2002001439A SV2003001439A (es) 2001-12-21 2002-12-18 Metodos y composiciones para el tratamiento de patologias respiratorias
UY27589A UY27589A1 (es) 2001-12-21 2002-12-18 Metodos y composiciones para el tratamiento de patologías respiratorias
ARP020104998A AR038042A1 (es) 2001-12-21 2002-12-19 Metodos y composiciones para el tratamiento de patologias respiratorias
US10/324,958 US20030125321A1 (en) 2001-12-21 2002-12-20 Methods and compositions for treating respiratory pathologies
CA002470442A CA2470442A1 (fr) 2001-12-21 2002-12-20 Methodes et compositions pour le traitement de pathologies respiratoires
PCT/FR2002/004506 WO2003053422A2 (fr) 2001-12-21 2002-12-20 Methodes et compositions pour le traitement de pathologies respiratoires
EP02805413A EP1455767A2 (fr) 2001-12-21 2002-12-20 Methodes et compositions pour le traitement de pathologies respiratoires
AU2002364679A AU2002364679A1 (en) 2001-12-21 2002-12-20 Method and compositions for treating respiratory pathologies
US10/498,094 US20050019314A1 (en) 2001-12-21 2002-12-20 Method and compositions for treating respiratory pathologies
PA20028562701A PA8562701A1 (es) 2001-12-21 2002-12-20 Metodos y composiciones para el tratamiento de patologias respiratorias
TW091136815A TW200305447A (en) 2001-12-21 2002-12-20 Methods and compositions for treating respiratory pathologies
PE2003000015A PE20030853A1 (es) 2001-12-21 2003-01-06 Metodos y composiciones para el tratamiento de patologias respiratorias

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116706A FR2833839A1 (fr) 2001-12-21 2001-12-21 Methodes et compositions pour le traitement de pathologies respiratoires
FR0208606A FR2833840B1 (fr) 2001-12-21 2002-07-09 Methodes et compositions pour le traitement de pathologies respiratoires

Publications (2)

Publication Number Publication Date
FR2833840A1 FR2833840A1 (fr) 2003-06-27
FR2833840B1 true FR2833840B1 (fr) 2010-06-18

Family

ID=26213306

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0208606A Expired - Fee Related FR2833840B1 (fr) 2001-12-21 2002-07-09 Methodes et compositions pour le traitement de pathologies respiratoires

Country Status (12)

Country Link
US (2) US20050019314A1 (fr)
EP (1) EP1455767A2 (fr)
AR (1) AR038042A1 (fr)
AU (1) AU2002364679A1 (fr)
CA (1) CA2470442A1 (fr)
FR (1) FR2833840B1 (fr)
PA (1) PA8562701A1 (fr)
PE (1) PE20030853A1 (fr)
SV (1) SV2003001439A (fr)
TW (1) TW200305447A (fr)
UY (1) UY27589A1 (fr)
WO (1) WO2003053422A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20050129679A1 (en) * 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
PT2336147E (pt) * 2003-12-17 2014-07-16 Janssen Alzheimer Immunotherap Conjugados transportadores de péptidos beta imunogénicos e seus processos de produção
AU2005277203A1 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
FR2879100B1 (fr) * 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
EP1951253A2 (fr) * 2005-10-26 2008-08-06 Cotherix, Inc. Fasudil en polytherapies pour traiter l'hypertension arterielle pulmonaire
EP2091551B1 (fr) * 2006-11-03 2020-01-15 Alba Therapeutics Corporation Procede de traitement de l'asthme
US20150038674A1 (en) * 2013-08-05 2015-02-05 Bayrak Bertan Boran Use of glp-2 analogues in pulmonary diseases for therapeutic purpose

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3748A (en) * 1844-09-17 Improvement in ratoon and cane cutters
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
FR2674434B1 (fr) * 1991-03-27 1993-06-18 Nativelle Sa Ets Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
US5336503A (en) * 1992-03-31 1994-08-09 Daiichi Pharmaceutical Co., Ltd. Anti-peptic ulcer agent
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
DE69420345T2 (de) * 1993-02-19 1999-12-30 Asahi Chemical Ind Benzothiazolsulfonamid-derivate, verfahren zu deren herstellung und anwendungen
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
NZ513800A (en) * 1996-08-12 2001-09-28 Welfide Corp Treatment of diseases using Rho kinase inhibitors
CA2302782A1 (fr) * 1997-09-19 1999-03-25 Magainin Pharmaceuticals, Inc. Facteurs associes a l'asthme comme cibles pour traiter les allergies atopiques y compris l'asthme et les troubles apparentes
WO2000003746A2 (fr) * 1998-07-14 2000-01-27 The Brigham And Women's Hospital, Inc. Remise a niveau de la synthase dl'oxyde nitrique des cellules endotheliales de type iii par des agents venant disloquer l'organisation cytosquelettique de l'actine
ES2284678T3 (es) * 2000-08-15 2007-11-16 Immunex Corporation Polipeptidos de claudinas.

Also Published As

Publication number Publication date
CA2470442A1 (fr) 2003-07-03
WO2003053422A2 (fr) 2003-07-03
AR038042A1 (es) 2004-12-22
TW200305447A (en) 2003-11-01
PA8562701A1 (es) 2004-02-16
EP1455767A2 (fr) 2004-09-15
WO2003053422A3 (fr) 2004-04-15
US20050019314A1 (en) 2005-01-27
AU2002364679A1 (en) 2003-07-09
PE20030853A1 (es) 2003-10-28
AU2002364679A8 (en) 2003-07-09
FR2833840A1 (fr) 2003-06-27
SV2003001439A (es) 2003-11-04
US20030125321A1 (en) 2003-07-03
UY27589A1 (es) 2003-05-30

Similar Documents

Publication Publication Date Title
NO20031471L (no) Glykoformer av faktor VII
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
ATE325612T1 (de) Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
MA27929A1 (fr) Utilisation de calcitonine pour le traitement de l'osteoarthrite
MA27998A1 (fr) Nouvelle formulation
ATE337780T1 (de) Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns
ES2194057T3 (es) Inhibidor de proteasa de leucocitos de secrecion (slpi) como inhibidor de triptasa.
DE60204217D1 (de) Verwendung von bioglas
DE60213407D1 (de) Zusammensetzungen zur hemmung der angiogenese
EA200400835A1 (ru) Электрод для активных форм кислорода и сенсор, использующий электрод
MXPA04004300A (es) Analogos de lipoxina a4.
FR2833840B1 (fr) Methodes et compositions pour le traitement de pathologies respiratoires
ATE259230T1 (de) Verwendung von vasopressin-antagonisten zur behandlung von störungen oder erkrankungen des innenohres
CA2527365A1 (fr) Compositions de prevention et de traitement de symptome de type rhume et grippe comprenant du zinc chelate
NO20072136L (no) Substans som fremmer GH-sekresjon og anvendelse derav
ATE406903T1 (de) Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater
SE9802794D0 (sv) New compounds
MA27539A1 (fr) Nouvelle combinaison synergique contenant du roflumilast et du formoterol
SE9802793D0 (sv) New compounds
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
AU5170400A (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
DE60230155D1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
CA2418506A1 (fr) Procede d'identification de substances influencant de maniere positive des etats inflammatoires de maladies inflammatoires chroniques des voies aeriennes
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120330